Harrow Health Inc.

HROW | NASDAQ

Price Alert Chart Builder DCF Calculator

$34.52

+$0.60 (+1.77%)

Sep 22, 2026, 2:43 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.26B

Enterprise Value $1.48B

Beta 0.24

Average Volume 729.91K

Shares Outstanding (Diluted) 37.35M

Shares Change YoY -3.87%

Institutional Ownership 57.52%

Exchange NASDAQ

ISIN US4158581094

Price Performance

Price Change 1M -15.8%

Price Change 3M -20.7%

Price Change 6M -6.7%

Price Change YTD -32.0%

Price Change 1Y -26.4%

Price Change 3Y 141.3%

Price Change 5Y 257.4%

1M CAGR (ann.) -16.1%

1Y CAGR (ann.) -25.3%

5Y CAGR (ann.) 29.1%

All-Time CAGR 1.5%

Valuation

PE Ratio -34.26

Forward PE 11.31

PEG Ratio 0.63

Forward PEG 0.01

PS Ratio 4.59

Forward PS 2.30

PB Ratio 83.18

P/FCF Ratio 222.37

P/Adj. FCF Ratio -912.90

P/OCF Ratio 199.53

EV/Sales 5.37

EV/EBIT -141.80

EV/EBITDA 330.41

EV/FCF 260.50

Earnings Yield -2.9%

FCF Yield 0.5%

Adj. FCF Yield -0.1%

Financial Health

Net Debt $216.86M

Total Debt $300.74M

Cash & Short-Term Investments $83.89M

Total Assets $416.82M

Current Ratio 2.24

Quick Ratio 2.08

Debt / Equity Ratio 19.79

Debt / EBITDA 67.09

Debt / FCF 52.89

OCF / Debt 0.02

Interest Coverage 0.25

Altman Z-Score 2.16

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 73.3%

Operating Profit Margin 2.1%

EBITDA Margin 1.6%

Net Profit Margin -13.5%

FCF Margin 2.1%

Adj. FCF Margin -0.5%

SBC / Revenue 2.6%

SBC Impact (per share) -124.4%

Returns

Return on Assets -8.9%

Return on Equity -103.9%

Return on Invested Capital 1.8%

Return on Capital Employed 1.8%

Return on Tangible Assets -15.5%

Historical Growth (CAGR)

Revenue CAGR 3Y 39.0%

Revenue CAGR 5Y 34.5%

Revenue CAGR 10Y 33.4%

EPS CAGR 3Y -2.7%

EPS CAGR 5Y 1.1%

EPS CAGR 10Y -21.6%

FCF CAGR 3Y 79.9%

FCF CAGR 5Y -8.8%

FCF CAGR 10Y -11.3%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 10

EPS Growth Next 3Y 237.7%

Revenue Growth Next 3Y 49.6%

Earnings Date Nov 8, 2026

EPS Estimate (next Q) $0.16

EPS Growth Est (next Q) 433.3%

Revenue Est (next Q) $99.07M

Revenue Growth Est (next Q) 38.3%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $66.50

Price Target Upside 96.0%

Cash Flow

Operating Cash Flow $6.25M

Free Cash Flow $5.69M

Adj. Free Cash Flow $-1.39M

FCF Per Share $0.15

OCF Per Share $0.17

OCF/S Ratio 2.3%

Income Statement

Revenue $275.59M

Gross Profit $201.96M

Operating Income $5.7M

EBITDA $4.48M

Net Income $-37.23M

EPS (Diluted) -$0.99

Revenue / Employee $738.86K

Profit / Employee $-99.8K

Employees 373